메뉴 건너뛰기




Volumn 26, Issue 9, 2017, Pages 867-869

Atrial Fibrillation: State of the Art in 2017 – Shifting Paradigms in Pathogenesis, Diagnosis, Treatment and Prevention

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

EID: 85026551075     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/S1443-9506(17)31276-3     Document Type: Editorial
Times cited : (3)

References (25)
  • 1
    • 85023765396 scopus 로고    scopus 로고
    • Epidemiology of Atrial Fibrillation: The Australian and Asia-Pacific Perspective
    • Wong, C.X., Brown, A., Tse, H.-F., Albert, C.M., Kalman, J.M., Marwick, T.H., et al. Epidemiology of Atrial Fibrillation: The Australian and Asia-Pacific Perspective. Heart Lung Circ 26:9 (2017), 870–879.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 870-879
    • Wong, C.X.1    Brown, A.2    Tse, H.-F.3    Albert, C.M.4    Kalman, J.M.5    Marwick, T.H.6
  • 2
    • 84896723562 scopus 로고    scopus 로고
    • Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study
    • Chugh, S.S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E.J., et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129 (2014), 837–847.
    • (2014) Circulation , vol.129 , pp. 837-847
    • Chugh, S.S.1    Havmoeller, R.2    Narayanan, K.3    Singh, D.4    Rienstra, M.5    Benjamin, E.J.6
  • 3
    • 85020675360 scopus 로고    scopus 로고
    • To Screen or Not to Screen? Examining the Arguments Against Screening for Atrial Fibrillation
    • Neubeck, L., Orchard, J., Lowres, N., Freedman, S.B., To Screen or Not to Screen? Examining the Arguments Against Screening for Atrial Fibrillation. Heart Lung Circ 26:9 (2017), 880–886.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 880-886
    • Neubeck, L.1    Orchard, J.2    Lowres, N.3    Freedman, S.B.4
  • 4
    • 85020463831 scopus 로고    scopus 로고
    • Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis
    • Lau, D.H., Linz, D., Schotten, U., Mahajan, R., Sanders, P., Kalman, J., Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis. Heart Lung Circ 26:9 (2017), 887–892.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 887-892
    • Lau, D.H.1    Linz, D.2    Schotten, U.3    Mahajan, R.4    Sanders, P.5    Kalman, J.6
  • 6
    • 84893558187 scopus 로고    scopus 로고
    • Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study
    • Marrouche, N.F., Wilder, D., Hindricks, G., Jais, P., Akoum, N., Marchlinski, F., et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 311 (2014), 498–506.
    • (2014) JAMA , vol.311 , pp. 498-506
    • Marrouche, N.F.1    Wilder, D.2    Hindricks, G.3    Jais, P.4    Akoum, N.5    Marchlinski, F.6
  • 7
    • 85021239664 scopus 로고    scopus 로고
    • Atrial Fibrillation and Sleep Apnoea: Guilt by Association?
    • Al-Falahi, Z., Williamson, J., Dimitri, H., Atrial Fibrillation and Sleep Apnoea: Guilt by Association?. Heart Lung Circ 26:9 (2017), 902–910.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 902-910
    • Al-Falahi, Z.1    Williamson, J.2    Dimitri, H.3
  • 8
    • 85023760315 scopus 로고    scopus 로고
    • An Update on Anticoagulation in Atrial Fibrillation
    • Amerena, J., Ridley, D., An Update on Anticoagulation in Atrial Fibrillation. Heart Lung Circ 26:9 (2017), 911–917.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 911-917
    • Amerena, J.1    Ridley, D.2
  • 9
    • 85021231068 scopus 로고    scopus 로고
    • Dealing with the Left Atrial Appendage for Stroke Prevention: Devices and Decision-Making
    • Phillips, K.P., Paul, V., Dealing with the Left Atrial Appendage for Stroke Prevention: Devices and Decision-Making. Heart Lung Circ 26:9 (2017), 918–925.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 918-925
    • Phillips, K.P.1    Paul, V.2
  • 10
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly, S.J., Ezekowitz, M.D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., et al., RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:12 (2009), 1139–1151.
    • (2009) N Engl J Med , vol.361 , Issue.12 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3    Eikelboom, J.4    Oldgren, J.5    Parekh, A.6
  • 11
    • 80052592404 scopus 로고    scopus 로고
    • ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • D. Patel, M.R., Mahaffey, K.W., Garg, J., Pan, G., Singer, D.E., Hacke, W., et al. ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:10 (2011), 883–891.
    • (2011) N Engl J Med , vol.365 , Issue.10 , pp. 883-891
    • D. Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3    Pan, G.4    Singer, D.E.5    Hacke, W.6
  • 12
    • 80052825103 scopus 로고    scopus 로고
    • ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation
    • Granger, C.B., Alexander, K.H., McMurray, J.J., Lopes, R.D., Hylek, E.M., Hanna, M., et al. ARISTOTLE Committees and Investigators Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:11 (2011), 981–992.
    • (2011) N Engl J Med , vol.365 , Issue.11 , pp. 981-992
    • Granger, C.B.1    Alexander, K.H.2    McMurray, J.J.3    Lopes, R.D.4    Hylek, E.M.5    Hanna, M.6
  • 13
    • 85026529684 scopus 로고    scopus 로고
    • Pharmacological therapy for rate and rhythm control in 2017
    • Kanagaratnam, L., Kower, P., Whalley, D., Pharmacological therapy for rate and rhythm control in 2017. Heart Lung Circ 26:9 (2017), 926–932.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 926-932
    • Kanagaratnam, L.1    Kower, P.2    Whalley, D.3
  • 14
    • 85021770987 scopus 로고    scopus 로고
    • Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation
    • Lau, D.H., Thiyagarajah, A., Willems, S., Rostock, T., Linz, D., Stiles, M., et al. Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation. Heart Lung Circ 26:9 (2017), 934–940.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 934-940
    • Lau, D.H.1    Thiyagarajah, A.2    Willems, S.3    Rostock, T.4    Linz, D.5    Stiles, M.6
  • 15
    • 33644653694 scopus 로고    scopus 로고
    • Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study)
    • Doshi, R.N., Daoud, E.G., Fellows, C., Turk, K., Duran, A., Hamdan, M.H., et al., PAVE Study Group. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 16:11 (2005), 1160–1165.
    • (2005) J Cardiovasc Electrophysiol , vol.16 , Issue.11 , pp. 1160-1165
    • Doshi, R.N.1    Daoud, E.G.2    Fellows, C.3    Turk, K.4    Duran, A.5    Hamdan, M.H.6
  • 16
    • 85022049037 scopus 로고    scopus 로고
    • Radiofrequency catheter ablation for atrial fibrillation: approaches and outcomes
    • Kalla, M., Sanders, P., Kalman, J.M., Lee, G., Radiofrequency catheter ablation for atrial fibrillation: approaches and outcomes. Heart Lung Circ 26:9 (2017), 941–949.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 941-949
    • Kalla, M.1    Sanders, P.2    Kalman, J.M.3    Lee, G.4
  • 17
    • 85021186797 scopus 로고    scopus 로고
    • Cryoablation for Atrial Fibrillation in 2017: what have we learned?
    • Shakkottai, P., Sy, R.W., McGuire, M.A., Cryoablation for Atrial Fibrillation in 2017: what have we learned?. Heart Lung Circ 26:9 (2017), 950–959.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 950-959
    • Shakkottai, P.1    Sy, R.W.2    McGuire, M.A.3
  • 18
    • 85020250298 scopus 로고    scopus 로고
    • Surgical and Hybrid Ablation of Atrial Fibrillation
    • Davies, R.A., Kumar, S., Chard, R.B., Thomas, S.P., Surgical and Hybrid Ablation of Atrial Fibrillation. Heart Lung Circ 26:9 (2017), 960–966.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 960-966
    • Davies, R.A.1    Kumar, S.2    Chard, R.B.3    Thomas, S.P.4
  • 19
    • 84859509560 scopus 로고    scopus 로고
    • 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
    • Calkins, H., Kuck, K.H., Cappato, R., Brugada, J., Camm, A.J., Chen, S.A., et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14:4 (2012), 528–606.
    • (2012) Europace , vol.14 , Issue.4 , pp. 528-606
    • Calkins, H.1    Kuck, K.H.2    Cappato, R.3    Brugada, J.4    Camm, A.J.5    Chen, S.A.6
  • 20
    • 84916931073 scopus 로고    scopus 로고
    • 2014 AHA/ACC/HRS guidelines for the management of patients with atrial fibrillation: executive summary: a report from the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society
    • January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cigarroa, J.E., Cleveland, J.C. Jr., et al., ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guidelines for the management of patients with atrial fibrillation: executive summary: a report from the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130:23 (2014), 2071–2104.
    • (2014) Circulation , vol.130 , Issue.23 , pp. 2071-2104
    • January, C.T.1    Wann, L.S.2    Alpert, J.S.3    Calkins, H.4    Cigarroa, J.E.5    Cleveland, J.C.6
  • 21
    • 84994501747 scopus 로고    scopus 로고
    • 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
    • Kirschhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:38 (2016), 2893–2962.
    • (2016) Eur Heart J , vol.37 , Issue.38 , pp. 2893-2962
    • Kirschhof, P.1    Benussi, S.2    Kotecha, D.3    Ahlsson, A.4    Atar, D.5    Casadei, B.6
  • 22
    • 85023739494 scopus 로고    scopus 로고
    • Atrial Fibrillation and Heart Failure — cause or effect?
    • Prabhu, S., Voskoboinik, A., Kaye, D.M., Kistler, P.M., Atrial Fibrillation and Heart Failure — cause or effect?. Heart Lung Circ 26:9 (2017), 967–974.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 967-974
    • Prabhu, S.1    Voskoboinik, A.2    Kaye, D.M.3    Kistler, P.M.4
  • 23
    • 85020057695 scopus 로고    scopus 로고
    • Atrial Fibrillation in Hypertrophic Cardiomyopathy
    • Vaidya, K., Semsarian, C., Chan, K.H., Atrial Fibrillation in Hypertrophic Cardiomyopathy. Heart Lung Circ 26:9 (2017), 975–982.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 975-982
    • Vaidya, K.1    Semsarian, C.2    Chan, K.H.3
  • 24
    • 85020462160 scopus 로고    scopus 로고
    • State of the Art Review: Atrial Fibrillation in Athletes
    • Flannery, M.D., Kalman, J.M., Sanders, P., La Gerche, A., State of the Art Review: Atrial Fibrillation in Athletes. Heart Lung Circ 26:9 (2017), 983–989.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 983-989
    • Flannery, M.D.1    Kalman, J.M.2    Sanders, P.3    La Gerche, A.4
  • 25
    • 85021169794 scopus 로고    scopus 로고
    • Risk Factor Management and Atrial Fibrillations Clinics: Saving the Best for Last?
    • Mahajan, R., Pathak, R., Thiyagarajah, A., Lau, D., Marchlinski, F., Dixit, S., et al. Risk Factor Management and Atrial Fibrillations Clinics: Saving the Best for Last?. Heart Lung Circ 26:9 (2017), 990–997.
    • (2017) Heart Lung Circ , vol.26 , Issue.9 , pp. 990-997
    • Mahajan, R.1    Pathak, R.2    Thiyagarajah, A.3    Lau, D.4    Marchlinski, F.5    Dixit, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.